BROMFED DM

This brand name is authorized in United States.

Active ingredients

The drug BROMFED DM contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII IXA7C9ZN03 - BROMPHENIRAMINE MALEATE
 
Read more about Brompheniramine
2
UNII 6V9V2RYJ8N - PSEUDOEPHEDRINE HYDROCHLORIDE
 

Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion.

 
Read more about Pseudoephedrine
3
UNII 9D2RTI9KYH - DEXTROMETHORPHAN HYDROBROMIDE
 

Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors.

 
Read more about Demorphan

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BROMFED DM Syrup MPI, US: SPL/Old FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 60432-837

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.